The Value of Mouse Models of Rare Diseases: A Spanish Experience

被引:16
作者
Murillo-Cuesta, Silvia [1 ,2 ,3 ]
Artuch, Rafael [1 ,4 ]
Asensio, Fernando [5 ]
de la Villa, Pedro [6 ]
Dierssen, Mara [1 ,7 ,8 ]
Enriquez, Jose Antonio [9 ,10 ]
Fillat, Cristina [1 ,11 ]
Fourcade, Stephane [1 ,12 ]
Ibanez, Borja [13 ,14 ]
Montoliu, Lluis [1 ,15 ]
Oliver, Eduardo [13 ]
Pujol, Aurora [1 ,12 ,16 ]
Salido, Eduardo [1 ,17 ]
Vallejo, Mario [2 ,18 ]
Varela-Nieto, Isabel [1 ,2 ,3 ]
机构
[1] Inst Hlth Carlos III, Biomed Res Networking Ctr Rare Dis CIBERER, Madrid, Spain
[2] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols IIBM, Madrid, Spain
[3] Hosp La Paz, Inst Hlth Res IdiPAZ, Madrid, Spain
[4] Inst Recerca St Joan Deu IRSJD, Barcelona, Spain
[5] Gregorio Maranon Inst Hlth Res IISGM, Madrid, Spain
[6] Univ Alcala UAH, Fac Med, Alcala De Henares, Spain
[7] Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain
[8] Univ Pompeu Fabra UPF, Barcelona, Spain
[9] Inst Hlth Carlos III, Spanish Natl Ctr Cardiovasc Res CNIC, Madrid, Spain
[10] Inst Hlth Carlos III, Biomed Res Networking Ctr Frailty & Hlth Ageing C, Madrid, Spain
[11] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain
[12] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain
[13] Inst Hlth Carlos III, Biomed Res Networking Ctr Cardiovasc Dis CIBERCV, Madrid, Spain
[14] Fdn Jimenez Diaz Univ Hosp Hlth Res Inst IIS FJD, Cardiol Dept, Madrid, Spain
[15] Spanish Natl Res Council, Natl Ctr Biotechnol CNB, Madrid, Spain
[16] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain
[17] Hosp Univ Canarias, Unidad Invest, Inst Tecnol Biomed ITB, San Cristobal la Laguna, Spain
[18] Inst Hlth Carlos III, Biomed Res Networking Ctr Diabet & Metab Dis CIBE, Madrid, Spain
关键词
orphan diseases; animal models; preclinical research; novel therapies; ethics; transparency; PRIMARY HYPEROXALURIA; OXIDATIVE STRESS; AXONAL DEGENERATION; HEARING-LOSS; NULL MICE; THERAPY; ADRENOLEUKODYSTROPHY; ABNORMALITIES; MITOCHONDRIAL; DEFICIENCY;
D O I
10.3389/fgene.2020.583932
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Animal models are invaluable for biomedical research, especially in the context of rare diseases, which have a very low prevalence and are often complex. Concretely mouse models provide key information on rare disease mechanisms and therapeutic strategies that cannot be obtained by using only alternative methods, and greatly contribute to accelerate the development of new therapeutic options for rare diseases. Despite this, the use of experimental animals remains controversial. The combination of respectful management, ethical laws and transparency regarding animal experimentation contributes to improve society's opinion about biomedical research and positively impacts on research quality, which eventually also benefits patients. Here we present examples of current advances in preclinical research in rare diseases using mouse models, together with our perspective on future directions and challenges.
引用
收藏
页数:9
相关论文
共 65 条
  • [1] Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery
    Ahmad, Gulzar
    Amiji, Mansoor
    [J]. DRUG DISCOVERY TODAY, 2018, 23 (03) : 519 - 533
  • [2] Inducible Slc7a7 Knockout Mouse Model Recapitulates Lysinuric Protein Intolerance Disease
    Bodoy, Susanna
    Sotillo, Fernando
    Espino-Guarch, Meritxell
    Sperandeo, Maria Pia
    Ormazabal, Aida
    Zorzano, Antonio
    Sebastio, Gianfranco
    Artuch, Rafael
    Palacin, Manuel
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [3] New models for human disease from the International Mouse Phenotyping Consortium
    Cacheiro, Pilar
    Haendel, Melissa A.
    Smedley, Damian
    Meehan, Terrence
    Mason, Jeremy
    Mashhadi, Hamed Haseli
    Munoz-Fuentes, Violeta
    Tocchini, Glauco
    Lloyd, Kent K. C.
    McKerlie, Colin
    Bower, Lynette
    Clary, Dave
    Nutter, Lauryl M. J.
    Flenniken, Ann M.
    Teboul, Lydia
    Codner, Gemma
    Wells, Sara
    Herault, Yann
    Sorg, Tania
    Vasseurm, Laurent
    Selloum, Mohammed
    Roux, Michel
    Jacobs, Hugues
    Meziane, Hamid
    Champy, Marie-France
    About, Ghina Bou
    Murray, Steve
    Chesler, Elissa
    Kumar, Vivek
    White, Jacqui
    Braun, Robert E.
    Beaudet, Arthur L.
    Dickinson, Mary E.
    Heaney, Jason D.
    Lorenzo, Isabel
    Lanza, Denise G.
    Reynolds, Corey L.
    Ward, Christopher S.
    Samaco, Rodney C.
    Veeraragavan, Surabi
    Hsu, Chih-Wei
    Christianson, Audrey E.
    Gallegos, Juan J.
    Seavitt, John Richard
    Gaspero, Angelina
    Green, Jennie R.
    Garza
    Garza, Arturo
    Bohat, Ritu
    Sedlacek, Radislav
    [J]. MAMMALIAN GENOME, 2019, 30 (5-6) : 143 - 150
  • [4] Cochlear abnormalities in insulin-like growth factor-1 mouse mutants
    Camarero, G
    Villar, MA
    Contreras, J
    Fernández-Moreno, C
    Pichel, JG
    Avendaño, C
    Varela-Nieto, I
    [J]. HEARING RESEARCH, 2002, 170 (1-2) : 2 - 11
  • [5] Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice
    Camarero, G
    Avendaño, C
    Fernández-Moreno, C
    Villar, A
    Contreras, J
    de Pablo, F
    Pichel, JG
    Varela-Nieto, I
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (19) : 7630 - 7641
  • [6] Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study
    Casasnovas, Carlos
    Ruiz, Montserrat
    Schluter, Agatha
    Naudi, Alba
    Fourcade, Stephane
    Veciana, Misericordia
    Castaner, Sara
    Alberti, Antonia
    Bargallo, Nuria
    Johnson, Maria
    Raymond, Gerald, V
    Fatemi, Ali
    Moser, Ann B.
    Villarroya, Francesc
    Portero-Otin, Manuel
    Artuch, Rafael
    Pamplona, Reinald
    Pujol, Aurora
    [J]. NEUROTHERAPEUTICS, 2019, 16 (04) : 1167 - 1182
  • [7] Sensorineural hearing loss in insulin-like growth factor I-null mice:: a new model of human deafness
    Cediel, R
    Riquelme, R
    Contreras, J
    Díaz, A
    Varela-Nieto, I
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 23 (02) : 587 - 590
  • [8] Efficacy and safety of AAV2 gene therapy in children with aromatic L-amino acid decarboxylase deficiency: an open-label, phase 1/2 trial
    Chien, Yin-Hsiu
    Lee, Ni-Chung
    Tseng, Sheng-Hong
    Tai, Chun-Hwei
    Muramatsu, Shin-ichi
    Byrne, Barry J.
    Hwu, Wuh-Liang
    [J]. LANCET CHILD & ADOLESCENT HEALTH, 2017, 1 (04) : 265 - 273
  • [9] Primary Hyperoxaluria
    Cochat, Pierre
    Rumsby, Gill
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (07) : 649 - 658
  • [10] Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
    Cochat, Pierre
    Hulton, Sally-Anne
    Acquaviva, Cecile
    Danpure, Christopher J.
    Daudon, Michel
    De Marchi, Mario
    Fargue, Sonia
    Groothoff, Jaap
    Harambat, Jerome
    Hoppe, Bernd
    Jamieson, Neville V.
    Kemper, Markus J.
    Mandrile, Giorgia
    Marangella, Martino
    Picca, Stefano
    Rumsby, Gill
    Salido, Eduardo
    Straub, Michael
    van Woerden, Christiaan S.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) : 1729 - 1736